Kirsten Nagashima

1. Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation
   2019/12/15 by Audrey Le Floc’h, Jeanne Allinne, Kirsten Nagashima +21 · 3 citations
   Immunology and Microbiology · Medicine · #Asthma and respiratory diseases #Dermatology and Skin Diseases #Psoriasis: Treatment and Pathogenesis